Dr. Joseph G Waller, M.D., M.P.H. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 1475 Kisker Rd Ste 180, Saint Charles, MO 63304 Phone: 636-442-7300 |
Dr. Matthew Edward Johnson, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 1475 Kisker Rd Ste 180, Saint Charles, MO 63304 Phone: 636-442-7300 |
Anna Liao Fu, MD Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 1475 Kisker Rd, Suite 180, Saint Charles, MO 63304 Phone: 636-442-7300 |
Dr. Christine Geraghty, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1475 Kisker Rd, Suite 160, Saint Charles, MO 63304 Phone: 636-498-7800 |
News Archive
AxoGen, Inc., a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced revenues for the first quarter ended March 31, 2012 of $1.65 million, a 47% increase over 2011 first quarter revenues of $1.12 million.
Racial disparities have previously been identified across a range of health care environments, sometimes extending into the highest levels of care. A new study led by researchers at Beth Israel Deaconess Medical Center reveals that while critical care outcomes in intensive care units (ICUs) steadily improved over a decade at hospitals with few minority patients, ICUs with a more diverse patient population did not progress comparably.
Our genes may have a bearing not only on our stroke risk, but probably also on how well we recover after stroke. For the first time, in international collaboration, scientists at the University of Gothenburg and elsewhere have identified common genetic variants that are associated with outcome after ischemic stroke.
KIYATEC, Inc. announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM) and other high-grade glioma (HGG) patients.
› Verified 5 days ago